NCT00414908View on ClinicalTrials.gov

A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

December 31, 2009

Conditions
Chronic PancreatitisPancreatectomyPancreatic Exocrine Insufficiency
Interventions
DRUG

Pancrelipase delayed release capsule

24,000 unit capsule

DRUG

Placebo Comparator

Placebo

Trial Locations (30)

Unknown

Site 9, Scottsdale

Site 22, Bristol

Site 7, Tampa

Site 6, Atlanta

Site 17, Chicago

Site 30, Maywood

Site 14, Indianapolis

Site 15, Kansas City

Site 16, Lexington

Site 12, New Orleans

Site 3, Boston

Site 2, Ann Arbor

Site 29, Grand Rapids

Site 1, Tupelo

Site 5, St Louis

Site 8, Cedar Knolls

Site 20, Boone

Site 4, Rutherford College

Site 10, Cincinnati

Site 11, Cleveland

Site 21, Pittsburgh

Site 13, Dallas

Site 18, Richmond

Site 23, Sofia

Site 27, Warsaw

Site 19, San Juan

Site 25, Saint Petersburg

Site 26, Belgrade

Site 24, Cape Town

Site 28, Kiev

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00414908 - A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy | Biotech Hunter | Biotech Hunter